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Background
Fibrosis determined by late enhancement (LE) is a pre-
dictor of progressive heart failure (HF) in dilated cardio-
myopathy (DCM). The mechanism responsible for this
association is not fully understood, though increased
ventricular stiffness could be involved. We therefore
hypothesised that pulmonary vascular resistance (PVR)
should be increased in patients with DCM and LE.
Methods
71 consecutive patients (p) with DCM, left ventricular sys-
tolic dysfunction (LVEF<35%) and normal coronary angio-
graphy followed in an outpatient HF clinic, were
prospectively enrolled in two institutions. All p had to be
in stable clinical condition in the last month. Exclusion
criteria were: contraindications for contrast-enhanced car-
diac MR (ce-CMR), significant impairment of lung func-
tion by clinical criteria or spirometry and history of
thromboembolic disease. All patients underwent ECG,
echo, blood test and a ce-CMR study in a Philips Intera ®
1.5 T scanner, which included cine imaging, phase con-
trast in the main pulmonary artery and aorta and late
enhancement (LE). Postprocessing was performed with
QMASS 7.2 ® (Medis, The Netherlands). PVR was calcu-
lated following the equation: 19.38 -(4.62*Ln pulmonary
artery average velocity) - (0.08 x RVEF %)
Results
Mean age was 61±12 years, 28 p (54%) were male. 41 p
(58%) were in functional class II and 10 p (14%) in class
III. 68 p(96%) were on beta-blockers, 61(86%) on ACE
inhibitors and 15 (21%) on angiotensin II receptor
antagonists. Mean LVEF was 29±10%. LE was normal in
37 p (52%), mesocardial in 23 p (39.6%), and subendo-
cardial in 5 p (7%). In a multivariant regression model
which included age, sex, LVEF, E/A ratio and the pre-
sence of any LE, the last three parameters were indepen-
dent predictors of PVR.
Conclusions
The presence of LE on CMR is a predictor of increased
RVP, showing complimentary value to LVEF.
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Table 1 Independent predictors of PVR
B (CI 95%) p
Age 0.02 (-0.04 - 0.08) NS
sex 0.05 (- 1.10 - 1.20) NS
E/A ratio 1.10 (0.15 - 2.05) 0.03
LVEF (%) -0.09 (-0.14 - (-0.03)) 0.01
LE (any) 2.08 (0.80 - 3.36) 0.003
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